174 related articles for article (PubMed ID: 16026742)
1. Renal, hematologic and infectious complications in multiple myeloma.
Bladé J; Rosiñol L
Best Pract Res Clin Haematol; 2005; 18(4):635-52. PubMed ID: 16026742
[TBL] [Abstract][Full Text] [Related]
2. Reversal of dialysis-dependent renal failure in patients with advanced multiple myeloma: single institutional experiences over 8 years.
Matsue K; Fujiwara H; Iwama K; Kimura S; Yamakura M; Takeuchi M
Ann Hematol; 2010 Mar; 89(3):291-7. PubMed ID: 19693498
[TBL] [Abstract][Full Text] [Related]
3. [The treatment of renal failure in multiple myeloma].
Adam Z; Krejcí M; Tichý M; Stepánková S; Pour L; Hájek R
Vnitr Lek; 2009 Jun; 55(6):570-82. PubMed ID: 19662889
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of renal insufficiency in patients with multiple myeloma].
Vulić D; Radlović O; Stanojcić A; Radmilović A; Rajić M
Srp Arh Celok Lek; 1996; 124 Suppl 1():53-5. PubMed ID: 9102930
[TBL] [Abstract][Full Text] [Related]
5. Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure.
Knudsen LM; Nielsen B; Gimsing P; Geisler C
Eur J Haematol; 2005 Jul; 75(1):27-33. PubMed ID: 15946307
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function.
Nozza A; Siracusano L; Armando S
Clin Ther; 2006 Jun; 28(6):953-9. PubMed ID: 16860177
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma in end-stage renal disease.
Penfield JG
Semin Dial; 2006; 19(4):329-34. PubMed ID: 16893412
[TBL] [Abstract][Full Text] [Related]
8. Myeloma kidney: pathogenesis and treatment.
Basić-Jukić N; Kes P; Labar B
Acta Med Croatica; 2001; 55(4-5):169-75. PubMed ID: 12398020
[TBL] [Abstract][Full Text] [Related]
9. [Development and treatment of renal insufficiency in multiple myeloma].
Mølby L; Hansen HH; Jensen EL
Ugeskr Laeger; 1994 Jul; 156(30):4343-7. PubMed ID: 8066935
[TBL] [Abstract][Full Text] [Related]
10. Renal disease and patient survival in light chain deposition disease.
Pozzi C; Fogazzi GB; Banfi G; Strom EH; Ponticelli C; Locatelli F
Clin Nephrol; 1995 May; 43(5):281-7. PubMed ID: 7634543
[TBL] [Abstract][Full Text] [Related]
11. Anemia in multiple myeloma.
Ludwig H; Pohl G; Osterborg A
Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
[TBL] [Abstract][Full Text] [Related]
12. [The kidney in dysproteinemia].
Spanti D; Marcantoni C; Di Landro D
G Ital Nefrol; 2005; 22 Suppl 33():S39-45. PubMed ID: 16419005
[TBL] [Abstract][Full Text] [Related]
13. The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure.
Raab MS; Breitkreutz I; Hundemer M; Benner A; Klaus J; Hegenbart U; Moehler T; Ho AD; Zeier M; Goldschmidt H
Haematologica; 2006 Nov; 91(11):1555-8. PubMed ID: 17082013
[TBL] [Abstract][Full Text] [Related]
14. Light-chain removal by plasmapheresis in myeloma-associated renal failure.
Cserti C; Haspel R; Stowell C; Dzik W
Transfusion; 2007 Mar; 47(3):511-4. PubMed ID: 17319833
[TBL] [Abstract][Full Text] [Related]
15. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
[TBL] [Abstract][Full Text] [Related]
16. Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care.
Hutchison CA; Harding S; Mead G; Goehl H; Storr M; Bradwell A; Cockwell P
Artif Organs; 2008 Dec; 32(12):910-7. PubMed ID: 19133018
[TBL] [Abstract][Full Text] [Related]
17. Role of erythropoietin in anemia after heart transplantation.
Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
19. [Selected renal complications during the course of multiple myeloma].
Sułowicz W; Sydor A; Króliczak M; Ochmański W; Giza D; Stompór T; Wolakiewicz M; Kupaj L
Przegl Lek; 1997; 54(12):835-40. PubMed ID: 9591450
[TBL] [Abstract][Full Text] [Related]
20. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.
Hutchison CA; Cockwell P; Reid S; Chandler K; Mead GP; Harrison J; Hattersley J; Evans ND; Chappell MJ; Cook M; Goehl H; Storr M; Bradwell AR
J Am Soc Nephrol; 2007 Mar; 18(3):886-95. PubMed ID: 17229909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
